cycloserine has been researched along with Day Blindness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
| Schindel, L | 1 |
| Pyle, MM | 1 |
| Radenbach, KL | 1 |
2 review(s) available for cycloserine and Day Blindness
| Article | Year |
|---|---|
[Clinically observed side effects of more recent antibiotics. Amphotericin-B-bacitracin-cycloserine-neomycin-novobiocin-polymyxin].
Topics: Adult; Amphotericin B; Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cycloserine; Drug Antagonism; Drug Hypersensitivity; Female; Hearing Disorders; Humans; Intestinal Diseases; Kidney Diseases; Liver Diseases; Male; Mental Disorders; Middle Aged; Neomycin; Novobiocin; Polymyxins; Stomach Diseases; Vision Disorders | 1966 |
Ethambutol and viomycin.
Topics: Adolescent; Aged; Body Weight; Child, Preschool; Cycloserine; Deafness; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Mycobacterium bovis; Mycobacterium Infections; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary; Viomycin; Vision Disorders; Visual Acuity | 1970 |
1 trial(s) available for cycloserine and Day Blindness
| Article | Year |
|---|---|
Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
Topics: Aged; Aminosalicylic Acids; Anti-Bacterial Agents; Berlin; Clinical Trials as Topic; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Hypocalcemia; Hypokalemia; Kidney Diseases; Middle Aged; Rifampin; Tetracycline; Tuberculosis, Pulmonary; Urea; Vision Disorders | 1969 |
1 other study(ies) available for cycloserine and Day Blindness
| Article | Year |
|---|---|
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |